Sep 8, 2026 · 7 min
Drug trial failure and cyberattack pressure major chipmaker
Novartis and Boston Scientific Slide; Intel Price Hikes
The episode connects fragile drug pipelines, operational cybersecurity risks, and semiconductor demand with the longer-term challenge of building smarter cities.
- 1Novartis faces renewed pipeline concerns after a late-stage muscle-wasting treatment failed its primary trial endpoint.
- 2Boston Scientific lowered its sales and earnings outlook after a cybersecurity incident disrupted operations.
- 3Intel may raise CPU prices as demand strengthens and investment in advanced manufacturing continues.
Don't miss
The report links Boston Scientific’s lowered outlook to a cybersecurity disruption, making an abstract digital threat concrete in financial terms.
The brief
The report opens with Novartis shares under pressure after a late-stage treatment for muscle-wasting disease failed its primary trial endpoint, intensifying questions about the company’s pipeline.
Boston Scientific then lowers its sales and earnings outlook after a cybersecurity incident disrupts operations, showing how digital threats can become an immediate financial problem.
The discussion turns to AI’s role in cybersecurity before examining Intel’s potential CPU price increases, strong demand, and reliance on advanced ASML lithography equipment.
The episode closes by widening the lens to rapidly growing cities, asking how AI, innovation, and long-term planning can produce smarter infrastructure, with Dubai as the example.
The central tension is whether technological progress can outpace the operational, manufacturing, and urban pressures created by faster growth.
What was said on this episode
7 statements · 3 positive · 4 negative
Novartis’s news is dragging down most biotech shares.
“The news also impacting the biotech space in general with most of the shares slumping.”
Listen at 1:24
Novartis’s news is dragging down Amgen shares.
“Shares of Amgen, for instance, which is in late-stage testing of its own heart disease medication, also being dragged down by this news from Novartis.”
Listen at 1:31
AI makes criminals’ cybersecurity tools exponentially more powerful.
“with AI, the tools that criminals have at their disposal are just exponentially more powerful, I would think.”
Listen at 3:16
The computer market is expected to shrink next year.
“the computer market is expected to shrink next year”
Listen at 4:05
AI will accelerate and compress processes in smart-city systems.
“AI will allow in the smart city space to compress a lot of things. The speed will change.”
Listen at 5:44
Dubai responded very well to its sudden population increase.
“they reacted very well to it.”
Listen at 6:10
Dubai has a long-term urban planning vision uncommon worldwide.
“They have a long-term urban planning vision, which again doesn't happen everywhere in the world.”
Listen at 6:12
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Bloomberg L.P.
Novo Nordisk
AmgenBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.